trial

The Significance of Deviation in Time From the 12-hour Standard Serum-clozapine Monitoring.

NCTId NCT02625103
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Completed
Enrollment 48 (actual)
Sponsored by Anders Fink-Jensen, MD, DMSci
Primary completion 2015-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Completed
Enrollment
48 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2015-09
Primary completion
2015-12
Eligibility
ALL · 18 Years · 64 Years

Interventions & indications

Drugs
Blood samplingClozapine

Sponsors

Anders Fink-Jensen, MD, DMSciLead Sponsor
University of CopenhagenCollaborator
Rigshospitalet, DenmarkCollaborator

Investigators

1
Anders Fink-Jensen, MD, professor, DMSci.Principal Investigator

Sites

1 total
Copenhagen, Denmark

Facts & assertions

4 sourced
Enrollment
48
Phase
PHASE4
Primary Completion Date
2015-12
Status
COMPLETED
relationships
The graph out of here
drug
Blood sampling
drug
Clozapine
drug
lead_sponsor
Anders Fink-Jensen, MD, DMSci
company
collaborator
University of Copenhagen
company
Rigshospitalet, Denmark
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Anders Fink-Jensen, MD, professor, DMSci.
person